Is Emtricitabine Capsule (Emtriva) in shortage?

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

• Emtriva, Capsule, 200 mg (NDC 61958-0601-1)
  Gilead Sciences, Inc.Being discontinuedUpdated Jun 17, 2026Discontinued Jun 17, 2026

  Product expected to be available until March 2027

  Maker contact: 800-445-3235

FDA recalls of Emtricitabine

Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Emtricitabine Capsule:

• Gilead Sciences, Inc. recalls Emtriva (emtricitabine) Oral Solution, 10 mg/mL, 170 mL bottles, Rx only, Manufactured for Gilead Sciences, Inc.,
  Oct 1, 2014Class II
• Gilead Sciences, Inc. recalls Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only,
  Sep 30, 2014Class III

Other forms on FDA’s list

• Emtricitabine Oral Solution